Borrelia burgdorferi

From Infogalactic: the planetary knowledge core
Jump to: navigation, search

<templatestyles src="Module:Hatnote/styles.css"></templatestyles>

Borrelia burgdorferi
File:Borrelia burgdorferi (CDC-PHIL -6631) lores.jpg
Borrelia burgdorferi
Scientific classification e
Kingdom: Bacteria
Phylum: Spirochaetes
Order: Spirochaetales
Family: Spirochaetaceae
Genus: Borrelia
Species: B. burgdorferi
Binomial name
Borrelia burgdorferi
Johnson et al. 1984 emend. Baranton et al. 1992

Lua error in Module:Taxonbar/candidate at line 22: attempt to index field 'wikibase' (a nil value). <templatestyles src="Module:Hatnote/styles.css"></templatestyles>

Borrelia burgdorferi is a bacterial species of the spirochete class of the genus Borrelia. B. burgdorferi exists in North America and Europe and is the predominant causative agent of Lyme disease in the United States. Borrelia species are considered diderm (double-membrane) bacteria rather than gram positive or negative.[1]

Microbiology

Borrelia burgdorferi is named after the researcher Willy Burgdorfer, who first isolated the bacterium in 1982.[2]

Morphology

B. burgdorferi resembles other spirochetes in that it has an outer membrane and inner membrane with a thin layer of peptidoglycan in between. However, the outer membrane lacks lipopolysaccharide. Its shape is a flat wave. It is about 0.3 μm wide and 5 to 20 μm in length.[3]

B. burgdorferi is an anaerobic, motile spirochete with seven to 11 bundled perisplasmic flagella set at each end that allow the bacterium to move in low- and high-viscosity media alike, which is related to its high virulence factor.[4]

Metabolism

B. burgdorferi is a slow-growing microaerophilic spirochete with a doubling time of 24 to 48 hours.[5] It is one of the few bacteria that can survive without iron, having replaced all of its iron-sulfur cluster enzymes with enzymes that use manganese, thus avoiding the problem many pathogenic bacteria face in acquiring iron.[6]

Life cycle

B. burgdorferi circulates between Ixodes ticks and a vertebrate host in an enzootic cycle. B. burgdorferi living in a tick cannot be passed to its offspring. Therefore, ticks must feed on the blood of an infected vertebrate to acquire B. burgdorferi. Infected ticks transmit B. burgdorferi by feeding on another vertebrate to complete the cycle.[7] Ticks can transmit B. burgdorferi to humans, but humans are dead-end hosts, unlikely to continue the life cycle of the spirochete.[8]

Disease

<templatestyles src="Module:Hatnote/styles.css"></templatestyles>

Lyme disease is a zoonotic, vector-borne disease transmitted by the Ixodes tick (also the vector for Babesia). The infected nymphal tick transmits B. burgdorferi via its saliva to the human during its blood meal.[9] In order for a successful infection, the vertebrate host reservoir must cultivate enough bacteria that can be circulated throughout the blood, so that B. burgodorferi can be transmitted through Ixodes blood feeding.[7] Additionally, the bacteria itself must withstand the molting and life cycle of the Ixodes tick and successfully transinfect a host for B. Burgdorferi to spread to humans.[7]

Clinical presentation of Lyme disease may include the characteristic bull's-eye rash and erythema chronicum migrans (a rash which spreads peripherally and spares the central part), as well as myocarditis, cardiomyopathy, arrythmia, arthritis, arthralgia, meningitis, neuropathies, and facial nerve palsy.[10]

Characteristic "bull's-eye" rash of Lyme disease

B. burgdorferi infections have been found in possible association with primary cutaneous B-cell lymphomas (PCBCLs),[11][12] where a review of the primary literature has, as of 2010, noted that most of the PCBLCs examined have been 'unresponsive' to antibiotics;[12]:846 hence, as in case of Chlamydophila psittaci association with ocular adnexal mucosa-associated lymphoid tissue (MALT) lymphoma, the working conclusion was that "if B. burgdorferi is truly associated with PCBCL, then there is wide geographic variability and other factors are probably involved".[12]:846

Progression of the disease follows from 3 stages.

Stage 1

Stage 1 affects the area around the bite, with a rash or swelling possible.

Stage 2

Stage 2 occurs weeks to months after; if left untreated, the bacteria spread through the body and affect the heart, bones, and nervous system.

Stage 3

Stage 3 occurs years after and chronic arthritis and neurological complications develop.[10][not in citation given]

Anaplasmosis and babesiosis are also common tick borne pathogens that infect humans similarly to Borrelia burgdorferi.[13] Consequently, it is possible for an Ixodes tick to coinfect a host with either two or all other diseases. When a host is coinfected, the combined effects of the diseases act synergistically, often proving to cause worse symptoms than a single infection alone[13] Coinfected humans tend to present with a more severe manifestation of Lyme disease. In addition, they tend to acquire a wider range of secondary symptoms, such as influenza-like symptoms.[13] More studies and research must be done to determine the synergistic effect of co-infection and its effect on the human body.

Variation of Severity

So far, there are three factors that may contribute to the severity of the clinical manifestation of Lyme Disease. The presence of ribosomal spacers, plasmids, and the outer surface protein C (OspC) are indicators of the severity of the infection.[14] Additionally, humans, themselves, vary in their response to the infection.[14] The variation in response leads to different clinical manifestations and different infections to different organs.

Molecular pathogenesis

Lua error in package.lua at line 80: module 'strict' not found.

After the pathogen is transmitted, it will acclimate to the mammalian conditions. Borrelia burgdorferi will change its glycoproteins and proteases on its plasma membrane to facilitate its dissemination throughout the blood.[14] While infecting, B. burgdorferi will express proteins that will interact with endothelial cells, platelets, chondrocytes, and the extracellular matrix.[14] This interaction inhibits proper function of the infected areas, leading to the pathological manifestations of Lyme disease. In response, the host will emit an inflammatory response to fight off the infection.[14]

Borrelia burgdorferi, also, expresses at least seven plasminogen binding proteins for interference of factor H at the activation level. This is part of a complement system evasion strategy that leads to downstream blocking of immune response.[15]

Genetics

B. burgdorferi (B31 strain) was the third microbial genome ever sequenced, following the sequencing of both Haemophilus influenzae and Mycoplasma genitalium in 1995. Its linear chromosome contains 910,725 base pairs and 853 genes.[16] The sequencing method used was whole genome shotgun. The sequencing project, published in Nature in 1997 and Molecular Microbiology in 2000, was conducted at The Institute for Genomic Research.[17] Overall, B. burgdorferi's genome oddly consists of one megabase chromosome and a variety of circular and linear plasmids ranging in size from 9 to 62 kilobases.[7] The megabase chromosome, unlike many other eubacteria, has no relation to neither the bacteria's virulence nor to the host-parasite interaction.[16] Some of the plasmids are necessary for the B. burgdorferi life cycle but not for propagation of the bacteria in culture.[7]

The genomic variations of Borrelia burgodrferi contribute to varying degrees of infection and dissemination.[18] Each genomic group has varying antigens on its membrane receptor, which are specific to the infection of the host. One such membrane receptor is the surface protein OspC.[18] The OspC surface protein is shown to be a strong indicator of the identification of genomic classification and the degree of dissemination.[18] Varying number of OspC loci are indications and determinants for the variations of Borrelia burdorferi.[18] The surface protein is also on the forefront of current vaccine research for Lyme disease via Borrelia.[19]

Evolution

Genetically diverse B. burgdorferi strains, as defined by the sequence of ospC, are maintained within the Northeastern United States. Balancing selection may act upon ospC or a nearby sequence to maintain the genetic variety of B. burgdorferi.[20] Balancing selection is the process by which multiple versions of a gene are kept within the gene pool at unexpectedly high frequencies. Two major models that control the selection balance of B.burgdorferi is negative frequency-dependent selection and multiple-niche polymorphism[21]. These models may explain how B. burgdorferi have diversified, and how selection may have affected the distribution of the B. burgdorferi variants, or the variation of specific traits of the species, in certain environments.

Negative-Frequency Dependent Selection

In negative frequency-dependent selection, rare and uncommon variants will have a selective advantage over variants that are very common in an environment.[21] For B. burgdorferi, low-frequency variants will be advantageous because potential hosts will not have a built immunological response to the variants specific OspC outer protein.[21]

Multiple-niche Polymorphism

Ecological niches are all of the variables in an environment, such as the resources, competitors, and responses, that contribute to the organism's fitness. Multiple-niche polymorphism states that diversity is maintained within a population due to the varying amount of possible niches and environments.[21] Therefore, the more various niches the more likelihood of polymophrism and diversity. For B. burgdorferi, varying vertebrae niches, such deer and mice, can affect the overall balancing selection for variants.[21]

See also

Further reading

  • Velázquez, Encarna, Peix, Álvaro & Gómez-Alonso, Alberto, 2011, "Microorganismos y cáncer: evidencias científicas y nuevas hipótesis", Cirugía Española, vol 89, no. 3, pages 136–144. ISSN 0009-739X; doi 10.1016/j.ciresp.2010.08.006; accessed 16 July 2015. English translation

References

  1. Lua error in package.lua at line 80: module 'strict' not found.
  2. Lua error in package.lua at line 80: module 'strict' not found.
  3. Lua error in package.lua at line 80: module 'strict' not found.
  4. Lua error in package.lua at line 80: module 'strict' not found.
  5. Lua error in package.lua at line 80: module 'strict' not found.
  6. Lua error in package.lua at line 80: module 'strict' not found.
  7. 7.0 7.1 7.2 7.3 7.4 Lua error in package.lua at line 80: module 'strict' not found.
  8. Lua error in package.lua at line 80: module 'strict' not found.
  9. Lua error in package.lua at line 80: module 'strict' not found.
  10. 10.0 10.1 Lua error in package.lua at line 80: module 'strict' not found.
  11. Lua error in package.lua at line 80: module 'strict' not found.
  12. 12.0 12.1 12.2 Lua error in package.lua at line 80: module 'strict' not found.
  13. 13.0 13.1 13.2 Lua error in package.lua at line 80: module 'strict' not found.
  14. 14.0 14.1 14.2 14.3 14.4 Lua error in package.lua at line 80: module 'strict' not found.
  15. Zipfel, P., Hallström, T., & Riesbeck, K. (2013). Human complement control and complement evasion by pathogenic microbes – Tipping the balance. Molecular Immunology, 56(3), 152-160.
  16. 16.0 16.1 Lua error in package.lua at line 80: module 'strict' not found.
  17. Lua error in package.lua at line 80: module 'strict' not found.
  18. 18.0 18.1 18.2 18.3 Lua error in package.lua at line 80: module 'strict' not found.
  19. Lua error in package.lua at line 80: module 'strict' not found.
  20. Lua error in package.lua at line 80: module 'strict' not found.
  21. 21.0 21.1 21.2 21.3 21.4 Lua error in package.lua at line 80: module 'strict' not found.

External links

de:Borrelien